New drug comparable to voriconazole for aspergillosisMarch 3, 2016Patient & Survivor CareCellular Therapy
Resources limit availability of bone marrow transplantsFebruary 9, 2016Multiple MyelomaCellular Therapy
Medicare to cover HSCT in approved clinical trials for myeloma, myelofibrosis, sickle cell diseaseJanuary 28, 2016Myelodysplastic SyndromeAnemiaMultiple MyelomaCellular TherapyBusiness of Medicine
CAR T-cells induce remissions, avoid GVHD in relapsed B-cell malignanciesJanuary 25, 2016ALLCellular Therapy
VIDEO: RBCs have extended shelf life, randomized trial showsDecember 6, 2015AnemiaCellular TherapyTransfusion Medicine
Big declines seen in aspergillosis mortalityOctober 9, 2015Patient & Survivor CareTransplantCellular Therapy
CTL019 induced a durable complete response in refractory MMSeptember 9, 2015Multiple MyelomaCellular Therapy
Guideline updated on hematopoietic colony-stimulating factorsJuly 14, 2015Patient & Survivor CareAggressive LymphomasCellular Therapy
CD8 cell dose predicts outcomes in allogeneic stem cell transplantation with reduced-intensity conditioningJune 8, 2015Myelodysplastic SyndromeAMLCellular Therapy
Chemotherapy and stem-cell transplantation combination appears safeApril 13, 2015Multiple MyelomaCellular Therapy
Chronic lymphocytic leukemia prognosis relatively good after transplantation failureApril 6, 2015CLLTransfusion MedicineCellular Therapy
CAR-T cell therapy rolls on in pediatric ALLDecember 17, 2014PediatricsTransfusion MedicineALLCellular Therapy
